[The reappearance of chancroid in Algeria] NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


[The reappearance of chancroid in Algeria]

Bull Soc Pathol Exot. 1992;85(4):276-8. Unique Identifier : AIDSLINE MED/93076117
Boudghene-Stambouli O; Merad-Boudia A; Aissa-Mamoun A; Service de Dermato-Venereologie, Centre; Hospitalo-Universitaire de Tlemcen, Algerie.

Abstract: After 35 observations of the chancroid observed in the department of dermato-venereology of the University Hospital of Tlemcen (West Algeria) from August 1988 to December 1991, we are led to analyze the flare of this sexual transmitted disease. The principal affected subjects are single male no older than 30 years, having had sexual intercourse with prostitutes (30/35). Less than 10 days (19/29) after the sexual contacts, the ulcer appears, and most often unique (25/35), mildly painful, accompanied frequently by adenopathies (31/35). The contamination took place mainly in Bel Abbes--city located at 90 km from Tlemcen--(12 cases), in Tlemcen (4 cases) and Morocco (5 cases). The treatment based on sulfonamides, erythromycin and tetracycline or doxycycline, has been constantly efficient. No concomitant HIV infection has been revealed. The chancroid is the first STD observed in our department in 1991, and also, the first cause for genital ulcer.
Keywords: Adult Algeria/EPIDEMIOLOGY Antibiotics/THERAPEUTIC USE Chancroid/DRUG THERAPY/*EPIDEMIOLOGY/ETIOLOGY *Disease Outbreaks English Abstract Hospitals, University Human Male Prostitution Risk Factors JOURNAL ARTICLEKWDadultalgeria/epidemiologyantibiotics/therapeuticusechancroid/drugtherapy/KWDepidemiology/etiologyKWDdiseaseoutbreaksenglishabstracthospitals,universityhumanmaleprostitutionriskfactorsjournalarticle
930330
M9331076

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .